Windlas Biotech Limited (WINDLAS.BO)
INR 924.95
(-0.21%)
INR 924.95
(-0.21%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 621.89 Million INR | -16.79% |
| 2022 | 747.38 Million INR | 27.3% |
| 2021 | 587.1 Million INR | 41.6% |
| 2020 | 414.61 Million INR | -15.93% |
| 2019 | 493.17 Million INR | 159.19% |
| 2018 | 190.27 Million INR | -45.92% |
| 2017 | 351.81 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q4 | 621.89 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 610.93 Million INR | 0.0% |
| 2023 FY | 621.89 Million INR | -16.79% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 747.38 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 747.38 Million INR | 27.3% |
| 2022 Q2 | 821.77 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 587.1 Million INR | 41.6% |
| 2021 Q4 | 587.1 Million INR | 0.0% |
| 2021 Q2 | 520.23 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 FY | 414.61 Million INR | -15.93% |
| 2020 Q4 | 414.61 Million INR | -11.35% |
| 2020 Q3 | 467.71 Million INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q4 | 493.17 Million INR | 0.0% |
| 2019 FY | 493.17 Million INR | 159.19% |
| 2018 FY | 190.27 Million INR | -45.92% |
| 2017 FY | 351.81 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 96.216% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 99.366% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 90.671% |
| Granules India Limited | 13 Billion INR | 95.218% |
| Indoco Remedies Limited | 3.53 Billion INR | 82.386% |
| Achyut Healthcare Limited | 568 Thousand INR | -109387.676% |
| Ajanta Pharma Limited | 8.28 Billion INR | 92.493% |
| Alkem Laboratories Limited | 26.61 Billion INR | 97.663% |
| Alpa Laboratories Limited | 136.65 Million INR | -355.087% |
| Brooks Laboratories Limited | 96.1 Million INR | -547.074% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | 72.71% |
| Bajaj HealthCare Limited | 1.44 Billion INR | 56.825% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | 47.496% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 99.021% |
| Eris Lifesciences Limited | 1.89 Billion INR | 67.101% |
| FDC Limited | 3.88 Billion INR | 84.009% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 97.525% |
| Gufic Biosciences Limited | 2 Billion INR | 68.98% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -494.672% |
| Ipca Laboratories Limited | 24.71 Billion INR | 97.484% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -314.676% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -534.815% |
| Lasa Supergenerics Limited | 190.43 Million INR | -226.565% |
| Laurus Labs Limited | 18.45 Billion INR | 96.63% |
| Lupin Limited | 49.53 Billion INR | 98.745% |
| Mankind Pharma Limited | 15.53 Billion INR | 95.997% |
| Medicamen Biotech Limited | 593.75 Million INR | -4.739% |
| Medico Remedies Limited | 163.37 Million INR | -280.659% |
| Megasoft Limited | - INR | -Infinity% |
| NATCO Pharma Limited | 7 Billion INR | 91.122% |
| Piramal Pharma Limited | 21.75 Billion INR | 97.142% |
| RPG Life Sciences Limited | 1.01 Billion INR | 38.427% |
| Sigachi Industries Limited | 707.2 Million INR | 12.064% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.37% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | 73.101% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -194.993% |
| Unichem Laboratories Limited | 7.04 Billion INR | 91.175% |
| Wanbury Limited | 360.23 Million INR | -72.636% |
| ZIM Laboratories Limited | 812.62 Million INR | 23.472% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 98.193% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Divi's Laboratories Limited | 31.84 Billion INR | 98.047% |
| Hester Biosciences Limited | 755.81 Million INR | 17.719% |
| Procter & Gamble Health Limited | 1.09 Billion INR | 43.003% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -115.152% |
| Bal Pharma Limited | 878.11 Million INR | 29.179% |
| Strides Pharma Science Limited | 11.26 Billion INR | 94.478% |
| Venus Remedies Limited | 1.21 Billion INR | 48.896% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 90.326% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 91.231% |
| Shilpa Medicare Limited | 3.44 Billion INR | 81.97% |
| Aarti Drugs Limited | 4.85 Billion INR | 87.201% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 85.362% |
| Suven Life Sciences Limited | 7.08 Million INR | -8677.558% |
| Ind-Swift Limited | 640.91 Million INR | 2.968% |
| Valiant Laboratories Limited | 100.15 Million INR | -520.934% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 87.624% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 82.711% |
| Themis Medicare Limited | 705.74 Million INR | 11.882% |
| Hikal Limited | 3.03 Billion INR | 79.524% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 97.271% |
| Sequent Scientific Limited | 3.46 Billion INR | 82.038% |
| Novartis India Limited | 448.6 Million INR | -38.629% |
| Wockhardt Limited | 6.4 Billion INR | 90.283% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 95.178% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -2339.071% |
| Neuland Laboratories Limited | 3.5 Billion INR | 82.253% |
| Morepen Laboratories Limited | 2.48 Billion INR | 74.984% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -1459.403% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | 49.701% |